FEB 27, 2019 8:00 AM PST

Prepare for success: GMP cell banks as part of a staged, standardized, platform-style cell production process

Speaker

Abstract
DATE:  February 27, 2019
TIME:  8:00am PST
 
Pluripotent stem cells (PSCs) can form any tissue or cell in the body, and are the ideal starting material to manufacture replacement organs and cellular therapies. Many groups have shown therapeutic proof-of-concept of PSC-derived cells or tissues in relevant animal models, but PSCs are still more of a promise than a reality because of manufacturing challenges.  The task of manufacturing a sufficient number of cells under Good Manufacturing Practices (GMP) to enable clinical trials and eventual commercialization is a substantial hurdle. Furthermore, all allogeneic therapies, including those derived from PSCs, must meet strict regulatory requirements. One such requirement is the need for extensive, costly characterization and safety testing of the parental cell line and the subsequent master and working cell banks (MCB/WCB). The time and expense required to complete this testing necessitates the MCB be of sufficient quality and size to meet not only the requirements of a Phase 1 regulatory filing (IND), but also for the lifetime of the product through late stage trials and commercialization. This presentation will focus on the “how and why” of integrating high quality ancillary raw materials into cell therapy product development and manufacturing workflow, beginning with the starting cell source and MCB.  Generation of a high-quality MCB is especially crucial for PSC-derived therapies because the first and most critically important step in product manufacturing is procurement of GMP-compliant starting material that meet regulatory requirements. Consequently, using high-quality raw materials from suppliers experienced in supporting cell therapy development and GMP manufacturing increase the probability of success and reduce the risk of costly surprises that could spell clinical or financial failure for a promising cell therapy product.  
 
Learning Objectives:
  • Understand how and why cell banking is used for cell therapy manufacturing
  • Understand how and why to incorporate quality reagents and raw materials early in the development process
 
Watch our related webinars here:
 
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
 

Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
JUL 15, 2021 9:00 AM PDT
JUL 15, 2021 9:00 AM PDT
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
APR 21, 2021 5:00 PM CEST
APR 21, 2021 5:00 PM CEST
Date: April 21, 2021 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Spatial Answers Trilogy - Spatial Answers in Immunology Immunology Researchers share their Spatial Discoveries in SARS-C...
FEB 27, 2019 8:00 AM PST

Prepare for success: GMP cell banks as part of a staged, standardized, platform-style cell production process


Specialty

Cell Biology

Biotechnology

Molecular Biology

Cancer Research

Clinical Research

Immunology

Cell Culture

Genetics

Molecular Diagnostics

Laboratory Testing

Medicine

Clinical Diagnostics

Drug Discovery

Biochemistry

Cancer Therapeutics

Geography

North America52%

Europe20%

Asia16%

South America6%

Africa4%

Oceania1%

Registration Source

Website Visitors54%

Email Promotions28%

WAVE Newsletter Promotion11%

Trending Newsletter Promotion2%

Client/Sponsor Promotions2%

Social Media Promotions1%

Website Banners1%

Other1%

Job Title

Research Scientist16%

Facility/Department Manager14%

Executive11%

Student11%

Medical Laboratory Technician8%

Scientist8%

Medical Doctor/Specialist5%

Clinical Laboratory Scientist5%

Educator/Faculty5%

Biologist3%

Consultant3%

Lab Management3%

QC/QA3%

Post Doc2%

Marketing/Sales2%

Engineer1%

Organization

Academic Institution22%

Biotech Company19%

Hospital10%

Clinical Laboratory6%

Research Institute5%

Life Science Company5%

Pharmaceutical Company3%

Consultant3%

Manufacturer & Biotech/pharma3%

Industrial Company3%

Medical Center2%

Medical School2%

Government2%

Contract Research Organization (Cro)2%

Other4%


Show Resources
Loading Comments...
Show Resources